85 related articles for article (PubMed ID: 20029948)
1. Endogenous thrombin potential in the assessment of hypercoagulability in systemic lupus erythematosus.
Mehta BM; Kiani AN; Chen C; Jani J; Kickler TS; Petri M
Am J Hematol; 2010 Jan; 85(1):83-5. PubMed ID: 20029948
[No Abstract] [Full Text] [Related]
2. Acquired free protein S deficiency is associated with antiphospholipid antibodies and increased thrombin generation in patients with systemic lupus erythematosus.
Ginsberg JS; Demers C; Brill-Edwards P; Bona R; Johnston M; Wong A; Denburg JA
Am J Med; 1995 Apr; 98(4):379-83. PubMed ID: 7709951
[TBL] [Abstract][Full Text] [Related]
3. Sole existence of antithrombin antibody in patients with systemic lupus erythematosus showing tendency of its antigenic determinants directing against exosite II (antithrombin/heparin binding site) of thrombin.
Matsuda J; Matsuyama A; Atsumi G; Ohkura N
Blood Coagul Fibrinolysis; 2008 Jan; 19(1):66-9. PubMed ID: 18180618
[TBL] [Abstract][Full Text] [Related]
4. [Antiphospholipid antibodies and epilepsy in patients with systemic lupus erythematosus].
Formiga F; Moga I; Canet R; Pac M; Mitjavila F; Pujol R
Rev Clin Esp; 1996 Nov; 196(11):734-6. PubMed ID: 9132835
[TBL] [Abstract][Full Text] [Related]
5. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus.
Danowski A; de Azevedo MN; de Souza Papi JA; Petri M
J Rheumatol; 2009 Jun; 36(6):1195-9. PubMed ID: 19447935
[TBL] [Abstract][Full Text] [Related]
6. Thrombin generation measured ex vivo following microvascular injury is increased in SLE patients with antiphospholipid-protein antibodies.
Musiał J; Swadźba J; Jankowski M; Grzywacz M; Bazan-Socha S; Szczeklik A
Thromb Haemost; 1997 Oct; 78(4):1173-7. PubMed ID: 9364980
[TBL] [Abstract][Full Text] [Related]
7. Clinical images: Anetoderma in systemic lupus erythematosus with antiphospholipid antibodies.
Venhoff N; Miehle N; Jüttner E; Peter HH; Walker UA
Arthritis Rheum; 2005 Jul; 52(7):2228. PubMed ID: 15986337
[No Abstract] [Full Text] [Related]
8. Thrombophilic patterns of coagulation factors in lupus.
Dhar JP; Andersen J; Essenmacher L; Ager J; Bentley G; Sokol RJ
Lupus; 2009 Apr; 18(5):400-6. PubMed ID: 19318391
[TBL] [Abstract][Full Text] [Related]
9. No increase of beta 2-glycoprotein I levels in patients with antiphospholipid antibodies.
De Benedetti E; Reber G; Miescher PA; de Moerloose P
Thromb Haemost; 1992 Nov; 68(5):624. PubMed ID: 1455413
[No Abstract] [Full Text] [Related]
10. [Antiphospholipid antibodies in systemic lupus erythematosus: study of a caseload of 120 patients].
Magarò M; Zoli A; Galossi A; Caricchio R; Mirone L; Scuderi F; Altomonte L
Ann Ital Med Int; 1994; 9(4):231-5. PubMed ID: 7893573
[TBL] [Abstract][Full Text] [Related]
11. [The heterogeneity of systemic lupus erythematosus due to the antiphospholipid syndrome].
Alekberova ZS; Nasonov EL; Stoianovich LZ
Ter Arkh; 1992; 64(5):77-9. PubMed ID: 1455383
[No Abstract] [Full Text] [Related]
12. Sudden sensorineural hearing loss in patients with systemic lupus erythematosus or lupus-like syndrome and antiphospholipid antibodies.
Paira SO
J Rheumatol; 1998 Dec; 25(12):2476-7. PubMed ID: 9858454
[No Abstract] [Full Text] [Related]
13. [Coronary disease during subacute lupus erythematosus].
Parodi A; Drosera M; Barbieri L; Rebora A
Ann Dermatol Venereol; 1998 Mar; 125(3):203. PubMed ID: 9747252
[No Abstract] [Full Text] [Related]
14. Sudden sensorineural hearing loss in patients with systemic lupus erythematosus or lupus-like syndromes and antiphospholipid antibodies.
Naarendorp M; Spiera H
J Rheumatol; 1998 Mar; 25(3):589-92. PubMed ID: 9517786
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the thrombin generation profile in systemic lupus erythematosus.
Kern A; Barabás E; Balog A; Burcsár S; Kiszelák M; Vásárhelyi B
Physiol Int; 2017 Mar; 104(1):35-41. PubMed ID: 28361572
[TBL] [Abstract][Full Text] [Related]
16. The presence of anti-phosphatidylserine/prothrombin antibodies as risk factor for both arterial and venous thrombosis in patients with systemic lupus erythematosus.
Nojima J; Iwatani Y; Suehisa E; Kuratsune H; Kanakura Y
Haematologica; 2006 May; 91(5):699-702. PubMed ID: 16627257
[TBL] [Abstract][Full Text] [Related]
17. Thrombosis of vascular access associated with factor V Leiden, antiphospholipid antibodies and antiheparin antibodies in a young woman on dialysis receiving warfarin following mitral valve replacement.
Molino D; De Lucia D; Perna AF; Cirillo M; De Santo NG
Nephrol Dial Transplant; 2006 Jun; 21(6):1719-20. PubMed ID: 16476715
[No Abstract] [Full Text] [Related]
18. Impact of markers of endothelial injury and hypercoagulability on systemic lupus erythematosus.
Cicarini WB; Duarte RCF; Ferreira KS; Loures CMG; Consoli RV; Neiva CLS; de Pádua PM; Nunes FFC; Alves LCV; Reis EA; Moreira CC; Guimarães TMPD; de Toledo VPCP; Carvalho MDG
Lupus; 2020 Feb; 29(2):182-190. PubMed ID: 31948350
[TBL] [Abstract][Full Text] [Related]
19. [Incidence of selected antiphospholipid antibodies in a group of patients with systemic lupus erythematosus].
Fojtík Z; Beránek M; Klabusay M; Korístek Z; Buliková A
Vnitr Lek; 2004 Apr; 50(4):267-73. PubMed ID: 15214295
[TBL] [Abstract][Full Text] [Related]
20. [Association of antiphospholipid antibodies with valvular heart disease in patients with systemic lupus erythematosus].
Hosaka K; Okada J; Ogiwara A; Kobayashi A; Kondo H
Ryumachi; 1994 Feb; 34(1):22-9. PubMed ID: 8146724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
